Found: 14
Select item for more details and to access through your institution.
Rationale for Raising Current Clinical Practice Guideline Target for Serum 25-Hydroxyvitamin D in Chronic Kidney Disease.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Real-world assessment: effectiveness and safety of extended-release calcifediol and other vitamin D therapies for secondary hyperparathyroidism in CKD patients.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Factors in nephrologists' decision to treat pre-dialysis CKD patients with vitamin D insufficiency and SHPT: A discrete choice experiment.
- Published in:
- PLoS ONE, 2023, v. 17, n. 3, p. 1, doi. 10.1371/journal.pone.0283531
- By:
- Publication type:
- Article
Effects of increasing doses of 1α-hydroxyvitamin D<sub>2</sub> on calcium homeostasis in postmenopausal osteopenic women.
- Published in:
- Journal of Bone & Mineral Research, 1994, v. 9, n. 5, p. 607, doi. 10.1002/jbmr.5650090504
- By:
- Publication type:
- Article
Unique 24-Hydroxylated Metabolites Represent a Significant Pathway of Metabolism of Vitamin D<sub>2 </sub>in Humans: 24-Hydroxyvitamin D<sub>2</sub> and 1,24- Dihydroxyvitamin D<sub>2 </sub>Detectable in Human Serum*.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 1998, v. 83, n. 6, p. 2156, doi. 10.1210/jcem.83.6.4841
- By:
- Publication type:
- Article
Evaluation of Therapies for Secondary Hyperparathyroidism Associated with Vitamin D Insufficiency in Chronic Kidney Disease.
- Published in:
- Kidney Diseases, 2023, v. 9, n. 3, p. 1, doi. 10.1159/000529523
- By:
- Publication type:
- Article
Alternate Approaches to a UMLS.
- Published in:
- Medical Decision Making, 1991, v. 11, n. 4S, p. S99, doi. 10.1177/0272989X9101100419
- By:
- Publication type:
- Article
Extended-Release Calcifediol Effectively Raises Serum Total 25-Hydroxyvitamin D Even in Overweight Nondialysis Chronic Kidney Disease Patients with Secondary Hyperparathyroidism.
- Published in:
- American Journal of Nephrology, 2022, v. 53, n. 6, p. 446, doi. 10.1159/000524289
- By:
- Publication type:
- Article
Real-World Assessment: Clinical Effectiveness and Safety of Extended-Release Calcifediol.
- Published in:
- American Journal of Nephrology, 2021, v. 52, n. 10/11, p. 798, doi. 10.1159/000518545
- By:
- Publication type:
- Article
Use of Extended-Release Calcifediol to Treat Secondary Hyperparathyroidism in Stages 3 and 4 Chronic Kidney Disease.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Modified-Release Calcifediol Effectively Controls Secondary Hyperparathyroidism Associated with Vitamin D Insufficiency in Chronic Kidney Disease.
- Published in:
- American Journal of Nephrology, 2015, v. 40, n. 6, p. 535, doi. 10.1159/000369939
- By:
- Publication type:
- Article
Modified-release calcifediol effectively controls secondary hyperparathyroidism associated with vitamin D insufficiency in chronic kidney disease.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Reference values for arm muscle area, arm fat area, subscapular skinfold thickness, and sum of skinfold thicknesses for American adults.
- Published in:
- 1984
- By:
- Publication type:
- journal article
Effective suppression of parathyroid hormone by lα-hydroxy- vitamin D<sub>2</sub> in hemodialysis patients with moderate to severe secondary hyperparathyroidism.
- Published in:
- Kidney International, 1997, v. 51, n. 1, p. 317, doi. 10.1038/ki.1997.39
- By:
- Publication type:
- Article